Search - tctmd.com

Displaying 321 - 340 of 706

Sort: Relevancy | Date

News Conference News AHA 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

Shelley Wood

November 06, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

PRECISE CT-Based Strategy Allows Clinicians to ‘Do Less’ for Stable Chest Pain

Yael L. Maxwell

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

RAPCO: Radial Artery Beats of Both RITA and Vein Grafting at 15 Years

News Conference News AHA 2022

RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years

Yael L. Maxwell

November 06, 2022

News Conference News AHA 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

Caitlin E. Cox

November 06, 2022

News Conference News AHA 2022

CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis

Yael L. Maxwell

November 05, 2022

News Conference News AHA 2022

IRONMAN Misses but Lends Support to IV Iron Repletion in HF

Shelley Wood

November 05, 2022

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Todd Neale

November 05, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Todd Neale

November 05, 2022

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

L.A. McKeown

November 04, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

CMS Final Rule Cuts Cardiology Reimbursement by 1% in 2023

News Daily News

CMS Final Rule for 2023 Physician Fee Schedule Gets Mixed Reactions

Yael L. Maxwell

November 02, 2022

News Daily News

ACC/AHA Release Updated Aortic Disease Guideline

Todd Neale

November 02, 2022

News Conference News AHA 2022

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

L.A. McKeown

November 01, 2022

News Conference News AHA 2022

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Yael L. Maxwell

November 01, 2022

News Daily News

Apixaban Again Linked to Less Bleeding in AF Patients

Michael O'Riordan

October 31, 2022

Advertisement

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

PRECISE CT-Based Strategy Allows Clinicians to ‘Do Less’ for Stable Chest Pain

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

CRISPR/Cas-9 Gene Editing Shows Promise in Transthyretin Amyloidosis

IRONMAN Misses but Lends Support to IV Iron Repletion in HF

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

CMS Final Rule for 2023 Physician Fee Schedule Gets Mixed Reactions

ACC/AHA Release Updated Aortic Disease Guideline

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Apixaban Again Linked to Less Bleeding in AF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content